Dogwood Therapeutics Inc (DWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,020 | 2,380 | 3,317 | 4,786 | 4,590 |
| TOTAL | $3,636 | $3,225 | $4,165 | $5,249 | $5,212 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $3,636 | $3,225 | $4,165 | $5,249 | $5,212 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 218 | 197 | 112 | 205 | 214 |
| Accrued Expenses | 282 | 373 | 247 | 282 | 306 |
| TOTAL | $500 | $570 | $359 | $487 | $520 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $500 | $570 | $359 | $487 | $520 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,110 | 770 | 770 | 770 | 770 |
| Common Shares | 3 | 2 | 0 | 2 | 2 |
| Retained earnings | -63,810 | -62,761 | -61,469 | -60,366 | -59,131 |
| Other shareholders' equity | -299 | -299 | -299 | -299 | -292 |
| TOTAL | $3,136 | $2,655 | $3,807 | $4,762 | $4,692 |
| Total Liabilities And Equity | $3,636 | $3,225 | $4,165 | $5,249 | $5,212 |